Holiferm
Holiferm is bringing biosurfactants to market and is in the process of building a ktonne scale sophorolipid manufacturing plant.
Holiferm has raised €24M across 2 funding rounds from 3 investors, most recently a Series B round in Jan 2024. Based in Manchester, UK; active in Cleantech. Data as of 28 Oct 2026.
Manchester, UKwww.holiferm.com ↗
Total raised
€24M
€23,737,541
Funding rounds
2
Investors
3
distinct backers
Active since
2023-07
latest 2024-01
Funding by year
EUR raised per yearHoliferm — funding by year — interactive chart.
Data table
| Holiferm — funding by year | |
|---|---|
| 2023 | €2.3M |
| 2024 | €21M |
Signals
High confidenceRaise-next likelihood21
base rate 48% for Series B
- ▼ Past typical raise window
- ▲ Up-round momentum
Exit likelihood9
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-08 | Series B | €21M | Clean Growth Fund,Rhapsody Venture Partners | View deal → |
| 2023-07-28 | Other | €2.3M | Greater Manchester Combined Authority (GMCA) | View deal → |